Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Smith

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Vaccine|March 22, 2021
Effect of a 2+1 schedule of ten-valent versus 13-valent pneumococcal conjugate vaccine on pneumococcal carriage: Results from a randomised controlled trial in VietnamBeth Temple, Monica Larissa Nation, Vo Thi Trang Dai, et al.
The Lancet Regional Health. Western Pacific|February 14, 2023
Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: results from a randomised controlled trialHeidi Smith-Vaughan, Beth Temple, Vo Thi Trang Dai, et al.
The Lancet. Infectious Diseases|June 30, 2022
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trialsAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
The Lancet Regional Health. Western Pacific|September 30, 2021
IMMUNOGENICITY AND IMPACT ON NASOPHARYNGEAL CARRIAGE OF A SINGLE DOSE OF PCV10 GIVEN TO VIETNAMESE CHILDREN AT 18 MONTHS OF AGERachel A Higgins, Beth Temple, Vo Thi Trang Dai, et al.
Frontiers in Pediatrics|February 3, 2022
Study Protocol for Preventing Early-Onset Pneumonia in Young Children Through Maternal Immunisation: A Multi-Centre Randomised Controlled Trial (PneuMatters)Anne B Chang, Maree Toombs, Mark D Chatfield, et al.
Plos Medicine|June 3, 2024
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedulesAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
The Lancet Regional Health. Western Pacific|February 16, 2026
<i>Streptococcus pneumoniae</i> nasopharyngeal carriage in Vietnamese children during the first five years of life: a post hoc analysisFernanda Marincek, Beth Temple, Sam Manna, et al.
The Journal of Infectious Diseases|March 12, 2026
Serotype-specific immunity and association with pneumococcal carriage following 3+1, 3+0 and 2+1 schedules of 10-valent pneumococcal conjugate vaccineDarren Suryawijaya Ong, Zheng Quan Toh, Beth Temple, et al.
BMJ Open|February 5, 2025
Azithromycin to prevent acute lower respiratory infections among Australian and New Zealand First Nations and Timorese children (PETAL trial): study protocol for a multicentre, international, double-blind, randomised controlled trialGabrielle B McCallum, Catherine A Byrnes, Peter S Morris, et al.
Genome Biology and Evolution|December 7, 2014
Global phylogenomic analysis of nonencapsulated Streptococcus pneumoniae reveals a deep-branching classic lineage that is distinct from multiple sporadic lineagesMarkus Hilty, Daniel Wüthrich, Susannah J Salter, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Vaccine|March 22, 2021
Effect of a 2+1 schedule of ten-valent versus 13-valent pneumococcal conjugate vaccine on pneumococcal carriage: Results from a randomised controlled trial in VietnamBeth Temple, Monica Larissa Nation, Vo Thi Trang Dai, et al.
The Lancet Regional Health. Western Pacific|February 14, 2023
Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: results from a randomised controlled trialHeidi Smith-Vaughan, Beth Temple, Vo Thi Trang Dai, et al.
The Lancet. Infectious Diseases|June 30, 2022
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trialsAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
The Lancet Regional Health. Western Pacific|September 30, 2021
IMMUNOGENICITY AND IMPACT ON NASOPHARYNGEAL CARRIAGE OF A SINGLE DOSE OF PCV10 GIVEN TO VIETNAMESE CHILDREN AT 18 MONTHS OF AGERachel A Higgins, Beth Temple, Vo Thi Trang Dai, et al.
Frontiers in Pediatrics|February 3, 2022
Study Protocol for Preventing Early-Onset Pneumonia in Young Children Through Maternal Immunisation: A Multi-Centre Randomised Controlled Trial (PneuMatters)Anne B Chang, Maree Toombs, Mark D Chatfield, et al.
Plos Medicine|June 3, 2024
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedulesAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
The Lancet Regional Health. Western Pacific|February 16, 2026
<i>Streptococcus pneumoniae</i> nasopharyngeal carriage in Vietnamese children during the first five years of life: a post hoc analysisFernanda Marincek, Beth Temple, Sam Manna, et al.
The Journal of Infectious Diseases|March 12, 2026
Serotype-specific immunity and association with pneumococcal carriage following 3+1, 3+0 and 2+1 schedules of 10-valent pneumococcal conjugate vaccineDarren Suryawijaya Ong, Zheng Quan Toh, Beth Temple, et al.
BMJ Open|February 5, 2025
Azithromycin to prevent acute lower respiratory infections among Australian and New Zealand First Nations and Timorese children (PETAL trial): study protocol for a multicentre, international, double-blind, randomised controlled trialGabrielle B McCallum, Catherine A Byrnes, Peter S Morris, et al.
Genome Biology and Evolution|December 7, 2014
Global phylogenomic analysis of nonencapsulated Streptococcus pneumoniae reveals a deep-branching classic lineage that is distinct from multiple sporadic lineagesMarkus Hilty, Daniel Wüthrich, Susannah J Salter, et al.
Pageof 8